Skip to content
Screener

Xylem XYL Restructuring and Asset Impairment Charges

Restructuring and Asset Impairment Charges at other companies

Howmet Aerospace logo
Howmet AerospaceHWM
-$93M-2,225%
Ciena logo
CienaCIEN
$1.5M-3.0%
Xylem logo
XylemXYL
$31M+47.6%
Smurfit Kappa Group logo
Smurfit Kappa GroupSW
$54M+260%
Staar Surgical logo
Staar SurgicalSTAA
$2.68M-88.2%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$796K+371%

Other financials

Income statement

See full
Revenue$2.3B+1.5%
Gross profit$963.0M+8.0%
Operating income$390.0M+27.9%
Net income$263.0M+16.4%
EPS (diluted)$1.11+19.4%

Balance sheet

See full
Cash & equivalents$1.3B+9.1%
Total debt$3.6B+63.6%
Total equity$10.4B-5.9%
Total assets$17.3B+0.9%

Cash flow

See full
Operating cash flow$290.0M-4.9%
CapEx$89.0M-9.2%
Free cash flow$201.0M-2.9%

Valuation

See full
Market cap$28.54B-18.3%
Enterprise value$30.85B-14.2%
P/E28×-9.2×
P/S3.1×-0.9×

Profitability

See full
Gross margin39.2%+1.4pp
Operating margin14.5%+2.1pp
Net margin11.2%+0.4pp
FCF margin10.5%+0.4pp

Returns & leverage

See full
Return on equity9.5%+0.7pp
Debt / equity0.3×+0.1×
Current ratio1.6×-0.3×